Under The Tree BioPharmaceuticals, or UTT BioPharma, is a pharmaceutical company specialising in the research and production of botanical drugs with a particular interest in the cannabis genus. Our immediate goal is to streamline the development and manufacturing of cannabinoid based medicine.

UTT BioPharma consists of a group of experts with the skills to run the process of cultivating, fractionating and purifying large quantities of raw materials in accordance with GxP standards and producing medical grade products following pharmaceutical industry guidelines.

Our Mission

We believe that the cannabis plant holds the key to significantly improving the lives of patients around the world. Our mission is to develop and build the infrastructure required to conduct the research enabling access to these benefits.

To achieve this UTT BioPharma has built a continuously growing network of experts and research institutes, promoting the integration of current global knowledge into all aspects of the development process.

While the provision of safe and effective cannabis derived medications is our priority, we want to help shape the changing political landscape, by providing high quality and evidenced based information to the public, law makers and patients. This will accelerate the development of a medical, political and social landscape in favour of a controlled entry of cannabis derived therapeutics into the market.

Our Management Team


Sergio Pagliazzi, Founder and CEO

A biopharmaceutical engineer by profession, Sergio has a invaluable experience in the pharmaceutical manufacturing sector from his time at CSL Behring and Kedrion S.p.A.

Sergio co-founded UTT BioPharma to develop and commercialize novel synergic medications for unmet medical needs. Sergio has laid down the framework for the complete GMP ‘seed to pill’ process based on his prior experience in the biologics sector, and has built a GMP supply chain with a network of manufacturers.


Abdul Rehman Mohammad, Co-founder & Director of Research and Regulatory Affairs

A qualified pharmacologist, Abdul was encapsulated by the therapeutic opportunities present in the cannabis plant.

Abdul co-founded UTT BioPharma with the aim of developing synergic therapeutics from the plant. In order to achieve this goal, Abdul has put together a team of reputable scientists at the University of Melbourne to undertake this research.

Feroz Mujtaba Rahman, Director of Engineering

As a biomolecular and chemical engineer, Feroz Mujtaba Rahman has vast experience in R&D, qualification and validation areas that he gained while working at CSL Behring.

Feroz specialises in processes driven from small scale R&D to commercial manufacturing in strict regulatory guidelines.

Our Scientific Advisors

  • advisor1

    Prof Terence O’Brien, The University of Melbourne, Melbourne, Australia


  • advisor2

    Dr Tina Soulis, The Florey Institute, Melbourne, Australia


  • advisor3

    Prof Nigel Bunnett, Monash University, Melbourne, Australia

  • advisor4

    Dr Miriam Melis, University of Cagliari, Cagliari, Italy


  • advisor5

    Prof Steven Petrou, The Florey Institute and The University of Melbourne, Melbourne, Australia

  • advisor6

    Prof David Castle, St Vincents Hospital and The University of Melbourne, Melbourne, Australia

  • advisor7

    Prof Geoff Stevens, The University of Melbourne, Melbourne, Australia


  • advisor8

    Dr Liana Fattore, National Research Council, Rome, Italy

  • advisor9

    Prof Toni Bacic, The University of Melbourne, Melbourne, Australia

  • advisor10

    Prof Ian Woodrow, The University of Melbourne, Melbourne, Australia

Our Strategic Partners

  • partners1

    The Florey Institute of Neuroscience and Mental Health

  • partners2

    Neuroscience Trials Australia

  • partners3

    ACS laboratories

  • partners4

    St Vincent’s Hospital, Melbourne